September 09, 2003; 61 (5) Special Articles
The utility of MRI in suspected MS
Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
E. M. Frohman, D. S. Goodin, P. A. Calabresi, J. R. Corboy, P. K. Coyle, M. Filippi, J. A. Frank, S. L. Galetta, R. I. Grossman, K. Hawker, N. J. Kachuck, M. C. Levin, J. T. Phillips, M. K. Racke, V. M. Rivera, W. H. Stuart
First published September 8, 2003, DOI: https://doi.org/10.1212/01.WNL.0000082654.99838.EF
E. M. Frohman
D. S. Goodin
P. A. Calabresi
J. R. Corboy
P. K. Coyle
M. Filippi
J. A. Frank
S. L. Galetta
R. I. Grossman
K. Hawker
N. J. Kachuck
M. C. Levin
J. T. Phillips
M. K. Racke
V. M. Rivera
The utility of MRI in suspected MS
Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
E. M. Frohman, D. S. Goodin, P. A. Calabresi, J. R. Corboy, P. K. Coyle, M. Filippi, J. A. Frank, S. L. Galetta, R. I. Grossman, K. Hawker, N. J. Kachuck, M. C. Levin, J. T. Phillips, M. K. Racke, V. M. Rivera, W. H. Stuart
Neurology Sep 2003, 61 (5) 602-611; DOI: 10.1212/01.WNL.0000082654.99838.EF
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 61 no. 5 602-611
PubMed:
Print ISSN:
Online ISSN:
History:
- Received December 12, 2002
- Accepted May 29, 2003
- First Published September 8, 2003.
Copyright & Usage:
© 2003
Author Disclosures
- E. M. Frohman, MD PhD,
- D. S. Goodin, MD,
- P. A. Calabresi, MD,
- J. R. Corboy, MD,
- P. K. Coyle, MD,
- M. Filippi, MD,
- J. A. Frank, MD,
- S. L. Galetta, MD,
- R. I. Grossman, MD,
- K. Hawker, MD,
- N. J. Kachuck, MD,
- M. C. Levin, MD PhD,
- J. T. Phillips, MD PhD,
- M. K. Racke, MD,
- V. M. Rivera, MD and
- W. H. Stuart, MD
- E. M. Frohman, MD PhD,
- D. S. Goodin, MD,
- P. A. Calabresi, MD,
- J. R. Corboy, MD,
- P. K. Coyle, MD,
- M. Filippi, MD,
- J. A. Frank, MD,
- S. L. Galetta, MD,
- R. I. Grossman, MD,
- K. Hawker, MD,
- N. J. Kachuck, MD,
- M. C. Levin, MD PhD,
- J. T. Phillips, MD PhD,
- M. K. Racke, MD,
- V. M. Rivera, MD and
- W. H. Stuart, MD
- From the University of Texas Southwestern Medical Center at Dallas (Drs. Frohman, Hawker, Phillips, and Racke); University of California at San Francisco (Dr. Goodin); University of Maryland (Dr. Calabresi), Baltimore; University of Colorado (Dr. Corboy), Denver; State University of New York (Dr. Coyle), Stony Brook; University of Milan (Dr. Filippi), Italy; National Institutes of Health (Dr. Frank), Bethesda, MD; University of Pennsylvania (Dr. Galetta), Philadelphia; New York University (Dr. Grossman), New York; University of Southern California (Dr. Kachuck), Los Angeles; University of Tennessee (Dr. Levin); Baylor College of Medicine (Dr. Rivera), Houston, TX; and Peachtree Neurological Clinic (Dr. Stuart), Atlanta, GA.
- Address correspondence and reprint requests to Dr. Elliot M. Frohman, University of Texas Southwestern Medical School, Department of Neurology, 5323 Harry Hines Boulevard, Dallas, TX 75235-9036; e-mail: elliot.frohman{at}utsouthwestern.edu; or Wendy S. Edlund, Manager, Clinical Practice Guidelines, American Academy of Neurology, 1080 Montreal Avenue, St. Paul, MN 55116; e-mail: wedlund@aan.com
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
- The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subc.
- B.M. J. Uitdehaag, VU Medical Centre, Amsterdam, bmj.uitdehaag@vumc.nl
- J.J.G. Geuerts, F. Barkhof, C.H. Polman
Submitted April 20, 2004 - Reply to Uitdehaag et al
- Douglas S. Goodin, MD, Chair, TTA Subcommittee, wedlund@aan.com
- Elliot M. Frohman, MD, PhD
Submitted April 20, 2004 - The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommitte
- Elliot M. Frohman, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390elliot.frohman@utsouthwestern.edu
Submitted October 13, 2003 - The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommitte
- James M Gordon, 1570 N 115th St., Suite 14, Seattle, WA 98133jgordon@nwhsea.org
Submitted October 13, 2003
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement